Dose and time-dependent selective neurotoxicity induced by mephedrone in mice

PLoS One. 2014 Jun 3;9(6):e99002. doi: 10.1371/journal.pone.0099002. eCollection 2014.

Abstract

Mephedrone is a drug of abuse marketed as 'bath salts". There are discrepancies concerning its long-term effects. We have investigated the neurotoxicity of mephedrone in mice following different exposition schedules. Schedule 1: four doses of 50 mg/kg. Schedule 2: four doses of 25 mg/kg. Schedule 3: three daily doses of 25 mg/kg, for two consecutive days. All schedules induced, in some animals, an aggressive behavior and hyperthermia as well as a decrease in weight gain. Mephedrone (schedule 1) induced dopaminergic and serotoninergic neurotoxicity that persisted 7 days after exposition. At a lower dose (schedule 2) only a transient dopaminergic injury was found. In the weekend consumption pattern (schedule 3), mephedrone induced dopamine and serotonin transporter loss that was accompanied by a decrease in tyrosine hydroxylase and tryptophan hydroxylase 2 expression one week after exposition. Also, mephedrone induced a depressive-like behavior, as well as a reduction in striatal D2 density, suggesting higher susceptibility to addictive drugs. In cultured cortical neurons, mephedrone induced a concentration-dependent cytotoxic effect. Using repeated doses for 2 days in an elevated ambient temperature we evidenced a loss of frontal cortex dopaminergic and hippocampal serotoninergic neuronal markers that suggest injuries at nerve endings.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Agents / toxicity*
  • Animals
  • Body Temperature / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • Corpus Striatum / metabolism
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Frontal Lobe / metabolism
  • Hippocampus / metabolism
  • Male
  • Methamphetamine / analogs & derivatives*
  • Methamphetamine / toxicity
  • Mice
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Serotonin Plasma Membrane Transport Proteins / metabolism
  • Time Factors
  • Tryptophan Hydroxylase / metabolism
  • Tyrosine 3-Monooxygenase / metabolism
  • Weight Gain / drug effects

Substances

  • Adrenergic Agents
  • Dopamine Plasma Membrane Transport Proteins
  • Serotonin Plasma Membrane Transport Proteins
  • Methamphetamine
  • mephedrone
  • Tyrosine 3-Monooxygenase
  • Tph2 protein, mouse
  • Tryptophan Hydroxylase

Grants and funding

Funding for this study was provided by grants from Generalitat de Catalunya (SGR977), Plan Nacional sobre Drogas (2010/005; 2012/102) and Ministerio de Ciencia e Innovación (SAF2010-15948). Martínez-Clemente is a recipient of a fellowship from the Plan Nacional sobre Drogas and López-Arnau is a recipient of a fellowship from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.